These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 22758607)

  • 21. Anticonvulsant properties of histamine H3 receptor ligands belonging to N-substituted carbamates of imidazopropanol.
    Sadek B; Shehab S; Więcek M; Subramanian D; Shafiullah M; Kieć-Kononowicz K; Adem A
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4886-91. PubMed ID: 23891186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticonvulsant effects of isomeric nonimidazole histamine H
    Sadek B; Saad A; Schwed JS; Weizel L; Walter M; Stark H
    Drug Des Devel Ther; 2016; 10():3633-3651. PubMed ID: 27853355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central histaminergic signalling, neural excitability and epilepsy.
    Yang L; Wang Y; Chen Z
    Br J Pharmacol; 2022 Jan; 179(1):3-22. PubMed ID: 34599508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histamine and selective H3-receptor ligands: a possible role in the mechanism and management of epilepsy.
    Vohora D; Pal SN; Pillai KK
    Pharmacol Biochem Behav; 2001 Apr; 68(4):735-41. PubMed ID: 11526971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease.
    Brioni JD; Esbenshade TA; Garrison TR; Bitner SR; Cowart MD
    J Pharmacol Exp Ther; 2011 Jan; 336(1):38-46. PubMed ID: 20864505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histamine pharmacology and new CNS drug targets.
    Tiligada E; Kyriakidis K; Chazot PL; Passani MB
    CNS Neurosci Ther; 2011 Dec; 17(6):620-8. PubMed ID: 22070192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticonvulsive effect of nonimidazole histamine H3 receptor antagonists.
    Sadek B; Kuder K; Subramanian D; Shafiullah M; Stark H; Lażewska D; Adem A; Kieć-Kononowicz K
    Behav Pharmacol; 2014 Jun; 25(3):245-52. PubMed ID: 24776492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histamine and schizophrenia.
    Arrang JM
    Int Rev Neurobiol; 2007; 78():247-87. PubMed ID: 17349864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic potential of thyreoliberin (TRH) and its analogues as antiepileptic and neuroprotective drugs].
    Jantas D
    Przegl Lek; 2010; 67(11):1179-85. PubMed ID: 21442973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic characterization of S 38093, a novel inverse agonist at histamine H3 receptors.
    Sors A; Panayi F; Bert L; Favale D; Nosjean O; Audinot V; Arrang JM; Buisson B; Steidl E; Delbos JM; Huhtala T; Kontkanen O; Chollet AM; Casara P; Lestage P
    Eur J Pharmacol; 2017 May; 803():11-23. PubMed ID: 28336400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-Hydroxypiperidines and Their Flexible 3-(Amino)propyloxy Analogues as Non-Imidazole Histamine H₃ Receptor Antagonist: Further Structure⁻Activity Relationship Exploration and In Vitro and In Vivo Pharmacological Evaluation.
    Olszewska B; Stasiak A; McNaught Flores D; Fogel WA; Leurs R; Walczyński K
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29671795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel steroidal histamine H
    Ledneczki I; Tapolcsányi P; Gábor E; Éles J; Greiner I; Schmidt É; Némethy Z; Kedves RS; Balázs O; Román V; Lévay G; Mahó S
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4525-4530. PubMed ID: 28888822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Neuroprotective Effects of Histamine H3 Receptor Antagonist E177 on Pilocarpine-Induced Status Epilepticus in Rats.
    Alachkar A; Azimullah S; Ojha SK; Beiram R; Łażewska D; Kieć-Kononowicz K; Sadek B
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31739417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological activity of novel tert-amylphenoxyalkyl (homo)piperidine derivatives as histamine H
    Kuder KJ; Łażewska D; Kaleta M; Latacz G; Kottke T; Olejarz A; Karcz T; Fruziński A; Szczepańska K; Karolak-Wojciechowska J; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2017 May; 25(10):2701-2712. PubMed ID: 28372935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive activity of the histamine H3 receptor.
    Arrang JM; Morisset S; Gbahou F
    Trends Pharmacol Sci; 2007 Jul; 28(7):350-7. PubMed ID: 17573125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interweaving epilepsy and neurodegeneration: Vitamin E as a treatment approach.
    Upaganlawar AB; Wankhede NL; Kale MB; Umare MD; Sehgal A; Singh S; Bhatia S; Al-Harrasi A; Najda A; Nurzyńska-Wierdak R; Bungau S; Behl T
    Biomed Pharmacother; 2021 Nov; 143():112146. PubMed ID: 34507113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.
    Sadek B; Schwed JS; Subramanian D; Weizel L; Walter M; Adem A; Stark H
    Eur J Med Chem; 2014 Apr; 77():269-79. PubMed ID: 24650714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histamine H3 receptor antagonists - Roles in neurological and endocrine diseases and diabetes mellitus.
    Abdulrazzaq YM; Bastaki SMA; Adeghate E
    Biomed Pharmacother; 2022 Jun; 150():112947. PubMed ID: 35447544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New developments around histamine H(3) receptor antagonists/inverse agonists: a patent review (2010 - present).
    Łażewska D; Kieć-Kononowicz K
    Expert Opin Ther Pat; 2014 Jan; 24(1):89-111. PubMed ID: 24131059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.